Immunome Cash Flow Statement
NASDAQ: IMNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
19.55+0.24 (+1.24%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Immunome free cash flow
In fiscal 2025, Immunome generated -$190.9 million of operating cash flow and spent $9.7 million on capital expenditures. That left free cash flow of -$200.6 million, a free-cash-flow margin of -2890.1% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Immunome cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -212.39M | -292.96M | -106.81M | -36.90M | -24.71M | -17.84M | -10.44M |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| Depreciation & Amortization | 2.47M | 1.57M | 457.00K | 422.00K | 755.00K | 755.00K | 615.00K |
| Stock-Based Compensation | 25.69M | 15.75M | 6.22M | 5.33M | 3.45M | 621.00K | 14.00K |
| Change in Working Capital | -19.59M | 1.39M | 11.23M | 4.39M | -2.50M | -1.91M | 22.00K |
| Operating Cash Flow | -190.92M | -110.79M | -7.57M | -28.69M | -18.23M | -12.13M | -9.60M |
| Capital Expenditures | -9.69M | -7.17M | -831.00K | -248.00K | -79.00K | -586.00K | -233.00K |
| Investing Cash Flow | 60.80M | -85.06M | -30.48M | -248.00K | -79.00K | -586.00K | -233.00K |
| Debt Issued | — | — | — | — | — | 500.00K | — |
| Financing Cash Flow | 640.36M | 240.53M | 116.41M | 32.00K | 27.77M | 49.94M | 10.77M |
| Net Change in Cash | 510.24M | 44.67M | 78.36M | -28.91M | 9.46M | 37.22M | 941.00K |
| Free Cash Flow | -200.60M | -117.97M | -8.40M | -28.94M | -18.30M | -12.72M | -9.83M |
This table shows 7 annual periods of Immunome's cash flow statement, from FY 2025 back to FY 2019, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IMNM's reporting calendar. What is a cash flow statement?